News &amp; Updates

Takotsubo syndrome (TS) more commonly occurs in patients aged <50 years and may result in severe complications that require intensive care, especially in younger individuals, reveals a study.

Younger Takotsubo syndrome patients at increased risk of severe complications

Ultrafine particles in air may increase 24-hour, diurnal DBP

An increase in ultrafine particles (UFP) concentrations during the day prior to ambulatory blood pressure monitoring (ABPM) appears to elevate the 24-hour and diurnal diastolic (D)BP, a study has shown.

Ultrafine particles in air may increase 24-hour, diurnal DBP

Factors affecting survival after haematopoietic cell transplantation for myelofibrosis

Patients with red blood cell transfusion dependence and an unfavourable molecular status suffer from worse relapse-free survival after haematopoietic cell transplantation for myelofibrosis, a recent study has shown.

Factors affecting survival after haematopoietic cell transplantation for myelofibrosis

The workplace: An avenue for hypertension management?

29 Apr 2020 by

A workplace-based hypertension management programme conducted in China resulted in improved blood pressure (BP) control and reduced hypertension rates.

The workplace: An avenue for hypertension management?

Atrial fibrillation ups risk of CVD, mortality in older hypertensive adults

In older adults with hypertension, the presence of atrial fibrillation may increase the risk of mortality, stroke, heart failure, fatal and nonfatal cardiovascular events, suggests a study.

Atrial fibrillation ups risk of CVD, mortality in older hypertensive adults

ACEIs, ARBs do not worsen COVID-19 in hypertensive patients

29 Apr 2020 by

Inhibitors of the renin-angiotensin system may not exacerbate the coronavirus disease 2019 (COVID-19) in patients with hypertension, according to a recent study.

ACEIs, ARBs do not worsen COVID-19 in hypertensive patients

Dumping ACEis/ARBs over COVID-19 concern? Not so fast

28 Apr 2020 by

There is currently no definite evidence showing that two classes of antihypertensive medications — ACE inhibitors and ARBs* — are linked to increased risk of COVID-19 infection, leading experts say. On the contrary, what is clear is that stopping these medications simply because of concern over their perceived theoretical risk can come at a price of adverse cardiovascular (CV) events.

Dumping ACEis/ARBs over COVID-19 concern? Not so fast

Slight elevations in uric acid may lead to excess mortality risk

Even a slight increase in serum uric acid concentrations may increase mortality risk in the general population, a recent study has found.

Slight elevations in uric acid may lead to excess mortality risk

COVID-19: Pharmacotherapy in Asia

28 Apr 2020 by

Representatives from five Asian countries shared local experiences and current protocols for pharmacotherapy in treating patients with COVID-19 at a recent Asian Young Pharmacists' Group (AYPG) webinar.

COVID-19: Pharmacotherapy in Asia